Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease

A Mitrofanova, S Merscher, A Fornoni - Nature Reviews Nephrology, 2023 - nature.com
Chronic kidney disease (CKD) is a global health problem with rising incidence and
prevalence. Among several pathogenetic mechanisms responsible for disease progression …

CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate

Y Chen, J Zhang, W Cui, RL Silverstein - Journal of Experimental …, 2022 - rupress.org
CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and
non-immune cells. It functions as both a signaling receptor responding to DAMPs and …

Lipid accumulation and chronic kidney disease

Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu… - Nutrients, 2019 - mdpi.com
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic
kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is …

Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease

J Baek, C He, F Afshinnia, G Michailidis… - Nature Reviews …, 2022 - nature.com
Dyslipidaemia is a hallmark of chronic kidney disease (CKD). The severity of dyslipidaemia
not only correlates with CKD stage but is also associated with CKD-associated …

CD36 in chronic kidney disease: novel insights and therapeutic opportunities

X Yang, DM Okamura, X Lu, Y Chen… - Nature Reviews …, 2017 - nature.com
CD36 (also known as scavenger receptor B2) is a multifunctional receptor that mediates the
binding and cellular uptake of long-chain fatty acids, oxidized lipids and phospholipids …

The cross‐link between ferroptosis and kidney diseases

J Wang, Y Liu, Y Wang, L Sun - Oxidative Medicine and …, 2021 - Wiley Online Library
Acute and chronic kidney injuries result from structural dysfunction and metabolic disorders
of the kidney in various etiologies, which significantly affect human survival and social …

Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases

HS Jang, MR Noh, J Kim, BJ Padanilam - Frontiers in medicine, 2020 - frontiersin.org
The kidney is a highly metabolic organ and uses high levels of ATP to maintain electrolyte
and acid-base homeostasis and reabsorb nutrients. Energy depletion is a critical factor in …

Evolving concepts in the pathogenesis of uraemic cardiomyopathy

X Wang, JI Shapiro - Nature Reviews Nephrology, 2019 - nature.com
The term uraemic cardiomyopathy refers to the cardiac abnormalities that are seen in
patients with chronic kidney disease (CKD). Historically, this term was used to describe a …

Protein interaction and Na/K-ATPase-mediated signal transduction

X Cui, Z Xie - Molecules, 2017 - mdpi.com
The Na/K-ATPase (NKA), or Na pump, is a member of the P-type ATPase superfamily. In
addition to pumping ions across cell membrane, it is engaged in assembly of multiple …

[HTML][HTML] New insights into renal lipid dysmetabolism in diabetic kidney disease

A Mitrofanova, G Burke, S Merscher… - World journal of …, 2021 - ncbi.nlm.nih.gov
Lipid dysmetabolism is one of the main features of diabetes mellitus and manifests by
dyslipidemia as well as the ectopic accumulation of lipids in various tissues and organs …